Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Vision‐related quality of life of myopic children using combination treatment: Atropine and defocus‐incorporated multiple segment spectacle lenses

View through CrossRef
Purpose: To assess vision‐related quality of life (VR‐QoL) in children undergoing myopia control treatment with atropine compared to children treated with combination treatment of atropine and Defocus incorporated multiple segments (DIMS) spectacle lenses.Methods: Longitudinal study that included myopic children aged 4 to 16 years undergoing myopia control treatment. Group A included children on 0.025% atropine eyedrops and single‐vision lenses, and group B included children on combined treatment of 0.025% atropine and DIMS lenses. Demographic and clinical data, including cycloplegic spherical equivalent refraction (SER) and axial length (AL), were noted. VR‐QoL was assessed using the Children's Visual Function questionnaire (CVFQ) and the Pediatric Eye Questionnaire (PedEyeQ) before initiating and after 6 months of treatment. Statistical analyses (Mann‐Whitney U‐test or t‐test) were performed.Results: 95 patients were included: 50 children in group A, mean age 8.94 ±2.50 years and 45 children in group B, mean age 9.51 ±2.46 years (p = 0.266). No significant differences were found in the overall VR‐QoL between both groups with PedEyeQ. Functional Vision and Social item scores (PedEyeQ) significantly improved at the 6M follow‐up in group A (p = 0.03 and p = 0.016, respectively) and group B (all p = 0.01). Scores on the Eye Condition item (PedEyeQ) at baseline and at 6M follow‐up were reversed; a decrease in group A, 89.73 [69.86‐89.73] and 64.98 [50.02‐74.99] (p < 0.01), and an increase in group B, 69.96 [69.96‐89.72] and 74.97 [43.62‐85] (p = 0.039). For the CVFQ, only Group B showed an improvement in General Vision (p = 0.049) and Competence (p = 0.031) scores.Conclusions: Myopic children treated with atropine and those using combination treatment (atropine and DIMS) do not seem to have significant differences in overall VR‐QoL following 6 months of treatment. General Vision (CVFQ), Competence (CVFQ) and Eye Condition (PedEyeQ) scores improve significantly for children on combination treatment.
Title: Vision‐related quality of life of myopic children using combination treatment: Atropine and defocus‐incorporated multiple segment spectacle lenses
Description:
Purpose: To assess vision‐related quality of life (VR‐QoL) in children undergoing myopia control treatment with atropine compared to children treated with combination treatment of atropine and Defocus incorporated multiple segments (DIMS) spectacle lenses.
Methods: Longitudinal study that included myopic children aged 4 to 16 years undergoing myopia control treatment.
Group A included children on 0.
025% atropine eyedrops and single‐vision lenses, and group B included children on combined treatment of 0.
025% atropine and DIMS lenses.
Demographic and clinical data, including cycloplegic spherical equivalent refraction (SER) and axial length (AL), were noted.
VR‐QoL was assessed using the Children's Visual Function questionnaire (CVFQ) and the Pediatric Eye Questionnaire (PedEyeQ) before initiating and after 6 months of treatment.
Statistical analyses (Mann‐Whitney U‐test or t‐test) were performed.
Results: 95 patients were included: 50 children in group A, mean age 8.
94 ±2.
50 years and 45 children in group B, mean age 9.
51 ±2.
46 years (p = 0.
266).
No significant differences were found in the overall VR‐QoL between both groups with PedEyeQ.
Functional Vision and Social item scores (PedEyeQ) significantly improved at the 6M follow‐up in group A (p = 0.
03 and p = 0.
016, respectively) and group B (all p = 0.
01).
Scores on the Eye Condition item (PedEyeQ) at baseline and at 6M follow‐up were reversed; a decrease in group A, 89.
73 [69.
86‐89.
73] and 64.
98 [50.
02‐74.
99] (p < 0.
01), and an increase in group B, 69.
96 [69.
96‐89.
72] and 74.
97 [43.
62‐85] (p = 0.
039).
For the CVFQ, only Group B showed an improvement in General Vision (p = 0.
049) and Competence (p = 0.
031) scores.
Conclusions: Myopic children treated with atropine and those using combination treatment (atropine and DIMS) do not seem to have significant differences in overall VR‐QoL following 6 months of treatment.
General Vision (CVFQ), Competence (CVFQ) and Eye Condition (PedEyeQ) scores improve significantly for children on combination treatment.

Related Results

IMPACT OF POSITIVE AND NEGATIVE LENS-INDUCED DEFOCUS ON CONTRAST SENSITIVITY IN MYOPIC AND NON-MYOPIC ADULTS
IMPACT OF POSITIVE AND NEGATIVE LENS-INDUCED DEFOCUS ON CONTRAST SENSITIVITY IN MYOPIC AND NON-MYOPIC ADULTS
Background: Lens-induced defocus (LID) alters contrast sensitivity (CS), a key determinant of visual performance, affecting both myopic and non-myopic individuals. Myopia, a preval...
The human axial length and choroidal thickness responses to continuous and alternating episodes of myopic and hyperopic blur
The human axial length and choroidal thickness responses to continuous and alternating episodes of myopic and hyperopic blur
Purpose To investigate the change in axial length (AxL) and choroidal thickness (ChT) in response to continuous and alternating episodes of monocular myopic and hyperopic defocus. ...
Features of Hemodynamics of Retinal Vessels in Hypermetropic and Myopic Defoci during Treatment with Orthokeratological Lenses
Features of Hemodynamics of Retinal Vessels in Hypermetropic and Myopic Defoci during Treatment with Orthokeratological Lenses
Conduct a study of the hemodynamics of retinal vessels in eyes with myopia with hypermetropic and myopic defocuses: 60 eyes (30 patients) with mild myopia and 100 eyes (50 patients...
Comparative effectiveness of defocus lenses, atropine, and their combined use for myopia control in children: A systematic review
Comparative effectiveness of defocus lenses, atropine, and their combined use for myopia control in children: A systematic review
To compare the effectiveness of defocus incorporated multiple segments (DIMS) lenses, atropine monotherapies, and their combination for myopia management in children. A systematic ...
Myopia Controlling using Low Dose Atropine Eye Drop
Myopia Controlling using Low Dose Atropine Eye Drop
Abstract Purpose: To determine myopic progression, axial length elongation, best-corrected visual acuity (BCVA), pupil dilation, and accommodatio...
Stability and Sterility of Extemporaneously Prepared 0.01% Atropine Ophthalmic Solution in Artificial Tears and Balanced Salt Solution
Stability and Sterility of Extemporaneously Prepared 0.01% Atropine Ophthalmic Solution in Artificial Tears and Balanced Salt Solution
Objective: The aim of this study was to investigate the physicochemical and microbiological stability of extemporaneously prepared 0.01% atropine ophthalmic solution in unopened ey...
Treatment Outcomes of Myopic Anisometropia with 1% Atropine
Treatment Outcomes of Myopic Anisometropia with 1% Atropine
ABSTRACT Purpose To investigate the safety and efficacy of the treatment of myopic anisometropia with 1% atropine. ...

Back to Top